Iktos announced research alliance with Almirall for new drug design
By Nikita Chaurasia  Date: 2019-12-14

Iktos announced research alliance with Almirall for new drug design
  • The new drug design to involve AI technology for optimization of advanced compounds and boosting up the identification if drug candidates for Almirall drug discovery program.
  • The agreement is likely to provide rapid identification of molecules for the satisfaction of multiple bioactivity for clinical trials.
  • Under the pact, Almirall would leverage Iktos’s AI accuracy to bring about a difference in the patients’ lives.

One of the prominent AI companies dealing in novel drug design, Iktos, has reportedly announced establishing a research partnership with leading skin-health focused pharmaceutical company, Almirall on the grounds of designing novel drug compounds via the use of Iktos’ AI technology.

As per reliable reports, Iktos’ AI technology offers high speed and efficiency to the drug discovery process through automatically designing virtual molecules that display desirable characteristics of an advanced drug candidate. This is apprehended to tacked one of the fundamental challenges in drug design which is the rapid and repetitive identification of molecules that authenticate the multiple bioactive attributes for testing.

On this acquisition, the executive Vice president R&D and Chief Scientific Officer of Almirall, Dr. Bhushan Hardas was quoted stating that the collaboration serves as an example of how the company intends to explore myriad possibilities served by the technology to discover new molecules and boost the clinical development. He further added that the company has planned to stand at the forefront of innovations to build holistic and transversal approaches in the medical field. AI is anticipated to offer Almirall a distinctive opportunity to amalgamate its skills with an intent to augmenting patients’ lives.

Meanwhile, the president and CEO of Iktos, Yann Gaston- Mathe, cited that the company is delighted to be partnered with Almirall as this collaboration would bolster the leadership position of the company in the domain of AI for new drug design. 

Iktos has of late announced umpteen collaborations and mergers with the biopharmaceutical companies where the company lays immense focus on accelerating the design of promising compounds.

Source credit: https://finance.yahoo.com/news/iktos-almirall-announce-research-collaboration-080100761.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Microsoft makes ‘carbon negative’ pledge to reach near zero emissions
Microsoft makes ‘carbon negative’ pledge to reach near zero emissions
By Nikita Chaurasia

Microsoft, a tech giant based in Redmond, Washington, has reportedly announced plans to go “carbon negative” by reducing carbon footprint from the atmosphere, by 2030. The technological company is placing strong emphasis on removing more...

Nissan, Renault denounce split rumors following Chairman Ghosn’s exit
Nissan, Renault denounce split rumors following Chairman Ghosn’s exit
By Nikita Chaurasia

The automakers ensure that the alliance was not under the danger of being dissolved. Renault shares have hit six years low after the split report. Automotive giants Nissan and Renault have recently denied reports of a possible split that resulte...

Visa to take over fintech firm ‘Plaid’ in $5.3 Bn acquisition deal
Visa to take over fintech firm ‘Plaid’ in $5.3 Bn acquisition deal
By Nikita Chaurasia

Visa, a financial services corporation, is reportedly acquiring Plaid, a start-up company based in San Francisco, in a deal worth $5.3 Bn. It is a long-term play that would position Visa as a leading company in the next decade and help Plaid scale it...

Dupont to invest $28Mn to produce advanced chip materials in S.Korea
Dupont to invest $28Mn to produce advanced chip materials in S.Korea
By Nikita Chaurasia

The company plans to develop a new facility in South Korea that would help reduce its dependency on Japan for semiconductor products. As Japan’s diplomatic relations with South Korea sour up, U.S. chemical company DuPont has revealed plans to...

Spotify unveils new streaming ad insertion tech to monetize podcasts
Spotify unveils new streaming ad insertion tech to monetize podcasts
By Nikita Chaurasia

Spotify Technology S.A., a Sweden based international media services provider, has reportedly announced a new podcast advertising technology called SAI (Streaming Ad Insertion) at the Consumer Electronics Show in Las Vegas. This new technology, for ...